Chemokine Decoy Receptors: New Players in Reproductive

Chemokines are multifunctional molecules with roles in leukocyte trafficking and developmental processes. Both fetal and maternal components of the placenta produce chemokines, which control leukocyte trafficking observed in the placenta. Thus, chemokines play roles in the balance between protection of the developing embryo/fetus and tolerance of its hemiallogeneic tissues. Recently, a group of chemokine receptors, which include D6, DARC, and CCX-CKR, have been described as “silent” receptors by virtue of their inability to activate signal transduction events leading to cell chemoattraction. Here we review in vitro and in vivo evidence indicating that chemokine “silent” receptors regulate innate and adaptive immunity behaving as decoy receptors that support internalization and degradation of chemotactic factors, and discuss available information on their potential role in reproductive immunology.

[1]  D. Greaves,et al.  The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization , 2008, Molecular Pharmacology.

[2]  J. M. Wessels,et al.  A Review of Molecular Contrasts Between Arresting and Viable Porcine Attachment Sites , 2007, American journal of reproductive immunology.

[3]  L. Salamonsen,et al.  Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. , 2007, Seminars in reproductive medicine.

[4]  N. Tanaka,et al.  Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. , 2007, Human pathology.

[5]  R. Berkowitz,et al.  Immune cell profiling in normal pregnancy, partial and complete molar pregnancy. , 2007, Gynecologic oncology.

[6]  S. Fujii,et al.  Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome. , 2007, Human reproduction.

[7]  Ann Richmond,et al.  Role of chemokines in tumor growth. , 2007, Cancer letters.

[8]  A. Ashkenazi,et al.  Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells , 2007, Angiogenesis.

[9]  R. Word,et al.  Cervical remodeling during pregnancy and parturition: molecular characterization of the softening phase in mice. , 2007, Reproduction.

[10]  J. Becker,et al.  Profiling Chemokines, Cytokines and Growth Factors in Human Early Pregnancy Decidua By Protein Array , 2007, American journal of reproductive immunology.

[11]  S. Quenby,et al.  Cervical leukocyte sub-populations in idiopathic preterm labour. , 2007, Journal of reproductive immunology.

[12]  Jose Rojas,et al.  Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator , 2007, Proceedings of the National Academy of Sciences.

[13]  M. Fried,et al.  Genome-Wide Expression Analysis of Placental Malaria Reveals Features of Lymphoid Neogenesis during Chronic Infection1 , 2007, The Journal of Immunology.

[14]  A. Chand,et al.  Reproductive Biology and Endocrinology Open Access Laser Capture Microdissection and Cdna Array Analysis of Endometrium Identify Ccl16 and Ccl21 as Epithelial-derived Inflammatory Mediators Associated with Endometriosis , 2007 .

[15]  C. Bleul,et al.  A silent chemokine receptor regulates steady-state leukocyte homing in vivo , 2007, Proceedings of the National Academy of Sciences.

[16]  R. Strieter,et al.  Chemokines as mediators of angiogenesis , 2007, Thrombosis and Haemostasis.

[17]  A. G. Betz,et al.  Periodic Accumulation of Regulatory T Cells in the Uterus: Preparation for the Implantation of a Semi-Allogeneic Fetus? , 2007, PloS one.

[18]  Barbara Schiessl,et al.  Inflammatory response in preeclampsia. , 2007, Molecular aspects of medicine.

[19]  K. Watabe,et al.  Interaction of Duffy antigen receptor for chemokines and KAI1: a critical step in metastasis suppression. , 2007, Cancer research.

[20]  A. Mantovani,et al.  Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 , 2007, Proceedings of the National Academy of Sciences.

[21]  M. E. Ferretti,et al.  Control of human trophoblast function , 2007, Reproductive biology and endocrinology : RB&E.

[22]  G. Mor,et al.  Trophoblast–Macrophage Interactions: a Regulatory Network for the Protection of Pregnancy , 2007, American journal of reproductive immunology.

[23]  G. Hair,et al.  Fetal cord blood mononuclear cells that are collected at term from HIV-1 infected women harbor transcriptionally active integrated proviral DNA. , 2006, American journal of obstetrics and gynecology.

[24]  T. Löning,et al.  Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications. , 2007, The American journal of pathology.

[25]  G. Chaouat,et al.  Immune cells in uteroplacental tissues throughout pregnancy: a brief review. , 2007, Reproductive biomedicine online.

[26]  D. Hassiakos,et al.  Possible Early Prediction of Preterm Birth by Determination of Novel Proinflammatory Factors in Midtrimester Amniotic Fluid , 2006, Annals of the New York Academy of Sciences.

[27]  G. Graham,et al.  Leucocyte expression of the chemokine scavenger D6. , 2006, Biochemical Society transactions.

[28]  R. Nibbs,et al.  Chemokine sequestration by atypical chemokine receptors. , 2006, Biochemical Society transactions.

[29]  A. Rot,et al.  Throwing light on DARC. , 2006, Biochemical Society transactions.

[30]  M. Kurrer,et al.  Constitutive Endocytosis of CD163 Mediates Hemoglobin-Heme Uptake and Determines the Noninflammatory and Protective Transcriptional Response of Macrophages to Hemoglobin , 2006, Circulation research.

[31]  F. Arechavaleta-Velasco,et al.  Transcytosis of Human immunodeficiency virus 1 across the placenta is enhanced by treatment with tumour necrosis factor alpha. , 2006, The Journal of general virology.

[32]  Graeme Milligan,et al.  The chemokine receptor CCX‐CKR mediates effective scavenging of CCL19 in vitro , 2006, European journal of immunology.

[33]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[34]  A. Laurence Location, movement and survival: the role of chemokines in haematopoiesis and malignancy , 2006, British journal of haematology.

[35]  Robin A. Weiss,et al.  The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes , 2005, Journal of Virology.

[36]  Alberto Mantovani,et al.  Increased inflammation in mice deficient for the chemokine decoy receptor D6 , 2005, European journal of immunology.

[37]  Z. Tian,et al.  Uterine natural killer cells: their choices, their missions. , 2005, Cellular & molecular immunology.

[38]  P. Wallace,et al.  Effect of the Menstrual Cycle on Immunological Parameters in the Human Female Reproductive Tract , 2005, Journal of acquired immune deficiency syndromes.

[39]  R. Nibbs,et al.  Post-translational control of chemokines: a role for decoy receptors? , 2005, Immunology letters.

[40]  D. Jackson,et al.  Rapid Plasma Membrane-Endosomal Trafficking of the Lymph Node Sinus and High Endothelial Venule Scavenger Receptor/Homing Receptor Stabilin-1 (Feel-1/Clever-1)* , 2004, Journal of Biological Chemistry.

[41]  Rebecca L. Jones,et al.  Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. , 2004, The Journal of clinical endocrinology and metabolism.

[42]  Stanislav Y. Shvartsman,et al.  Argos inhibits epidermal growth factor receptor signalling by ligand sequestration , 2004, Nature.

[43]  L. Gardner,et al.  The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. , 2004, Biochemical and biophysical research communications.

[44]  Alberto Mantovani,et al.  β-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6* , 2004, Journal of Biological Chemistry.

[45]  M. Uguccioni,et al.  Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5 , 2004, Journal of Biological Chemistry.

[46]  K. Red-Horse,et al.  Human pregnancy: the role of chemokine networks at the fetal–maternal interface , 2004, Expert Reviews in Molecular Medicine.

[47]  R. Nibbs,et al.  The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. , 2004, Molecular biology of the cell.

[48]  M. Gobbi,et al.  Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor1 , 2004, The Journal of Immunology.

[49]  D. Townson,et al.  Chemokines in the corpus luteum: Implications of leukocyte chemotaxis , 2003, Reproductive biology and endocrinology : RB&E.

[50]  B. Rueda,et al.  Microvascular endothelial cells of the corpus luteum , 2003, Reproductive biology and endocrinology : RB&E.

[51]  M. Monden,et al.  A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. , 2003, International immunology.

[52]  Janet S. Lee,et al.  References Subscriptions Permissions Email Alerts Duffy Antigen Facilitates Movement of Chemokine Across the Endothelium In Vitro and Promotes Neutrophil Transmigration In , 2013 .

[53]  C. Simón,et al.  Hormonal and embryonic regulation of chemokine receptors CXCR1, CXCR4, CCR5 and CCR2B in the human endometrium and the human blastocyst. , 2003, Molecular human reproduction.

[54]  H. Kusuhara,et al.  A role of the Duffy antigen for the maintenance of plasma chemokine concentrations. , 2003, Biochemical and biophysical research communications.

[55]  M. Gobbi,et al.  Cutting Edge: Scavenging of Inflammatory CC Chemokines by the Promiscuous Putatively Silent Chemokine Receptor D6 1 , 2003, The Journal of Immunology.

[56]  L. Salamonsen,et al.  Leukocyte networks and human endometrial remodelling. , 2002, Journal of reproductive immunology.

[57]  P. Murphy International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature , 2002, Pharmacological Reviews.

[58]  Giselle Chamberlain,et al.  Expression of the Duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium , 2002, The Journal of pathology.

[59]  R. Nibbs,et al.  Characterization of mouse CCX‐CKR, a receptor for the lymphocyte‐attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP‐3β/mCCL19: comparison to human CCX‐CKR , 2002, European journal of immunology.

[60]  U. Kayisli,et al.  Uterine Chemokines in Reproductive Physiology and Pathology , 2002, American journal of reproductive immunology.

[61]  A. Arıcı Local Cytokines in Endometrial Tissue: The Role of Interleukin‐8 in the Pathogenesis of Endometriosis , 2002, Annals of the New York Academy of Sciences.

[62]  W. König,et al.  Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells , 2001, Parasitology Research.

[63]  M. Nebuloni,et al.  Malaria placental infection with massive chronic intervillositis in a gravida 4 woman. , 2001, Human pathology.

[64]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[65]  D. Kerjaschki,et al.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.

[66]  Yu Wang,et al.  Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK , 2000, The Journal of Immunology.

[67]  A. Arıcı,et al.  Leukocytes in ovarian function. , 2000, Human reproduction update.

[68]  E. S. Baekkevold,et al.  Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. , 1999, The American journal of pathology.

[69]  A. Mantovani,et al.  The chemokine system: redundancy for robust outputs. , 1999, Immunology today.

[70]  A. Arıcı,et al.  Chemokines and human reproduction. , 1999, Fertility and sterility.

[71]  A. Richmond,et al.  Multiple chemotactic factors: fine control or redundancy? , 1999, Trends in pharmacological sciences.

[72]  C. Menéndez,et al.  Massive chronic intervillositis of the placenta associated with malaria infection. , 1998, The American journal of surgical pathology.

[73]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[74]  R. Nibbs,et al.  Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.

[75]  Zhaohua Lu,et al.  The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.

[76]  R. Horuk,et al.  Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. , 1994, The Journal of clinical investigation.

[77]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[78]  A. J. Valente,et al.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. , 1991, The Journal of clinical investigation.

[79]  M. Tanner,et al.  Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. , 1990, Journal of immunology.

[80]  L. Miller,et al.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.